Can CRISPR And 3 Small Biotech Companies Cure 10000 Diseases? – Investor’s Business Daily
Investor’s Business Daily |
Can CRISPR And 3 Small Biotech Companies Cure 10000 Diseases?
Investor’s Business Daily For in vivo applications, when gene editing is done inside the body, Crispr Therapeutics says it uses several approaches to ensure transient expression of the Cas9 enzyme. Because of that, "we do not expect pre-existing immunity to Cas9 to cause any … |
